1959:TSEKRAFTIA CORPORATION Analysis
Data as of 2026-03-15 - not real-time
₩1,430.00
Latest Price
8/10Risk
Risk Level: High
Executive Summary
The stock is trading below its 20‑day simple moving average and also beneath the 50‑day SMA, indicating a sustained downtrend. The 14‑day RSI hovers around the mid‑40s, suggesting neither extreme oversold nor overbought conditions. MACD shows a bearish divergence, with the histogram deepening into negative territory. Trading volume has been on an upward trajectory, reinforcing the bearish price action.
On the fundamentals side, revenue has contracted sharply, delivering a negative growth rate. Gross and operating margins are deeply negative, and the company posted a sizable net loss. Debt levels far exceed cash reserves, driving a debt‑to‑equity ratio well above 20. Operating and free cash flows are strongly negative, eroding financial flexibility. The firm does not pay a dividend, and its price‑to‑sales multiple is modest, reflecting distressed valuation. Combined with a low beta, the stock exhibits limited market volatility but heightened company‑specific risk. Given these dynamics, the outlook remains cautious across horizons.
On the fundamentals side, revenue has contracted sharply, delivering a negative growth rate. Gross and operating margins are deeply negative, and the company posted a sizable net loss. Debt levels far exceed cash reserves, driving a debt‑to‑equity ratio well above 20. Operating and free cash flows are strongly negative, eroding financial flexibility. The firm does not pay a dividend, and its price‑to‑sales multiple is modest, reflecting distressed valuation. Combined with a low beta, the stock exhibits limited market volatility but heightened company‑specific risk. Given these dynamics, the outlook remains cautious across horizons.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- price below key moving averages
- bearish MACD histogram
- increasing volume confirming downtrend
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- low beta suggesting limited market volatility
- potential support near moving averages
- uncertain turnaround prospects
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- persistent negative margins and cash flow
- high debt relative to cash
- absence of dividend and weak valuation metrics
Key Metrics & Analysis
Financial Health
Revenue Growth-40.70%
Profit Margin-193.54%
ROE-73.29%
ROA-3.81%
Debt/Equity25.71
Op. Cash Flow₩-9689022464
Free Cash Flow₩-12041476096
Industry P/E29.1
Technical Analysis
TrendBearish
RSI45.7
Support₩0.00
Resistance₩2,140.00
MA 20₩1,672.00
MA 50₩2,108.40
MA 200₩2,478.60
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
GradeUndervalued
TypeValue
Risk Assessment
Beta0.10
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.